Disease | multiple endocrine neoplasia type 1 |
Symptom | C0020502|hyperparathyroidism |
Sentences | 13 |
PubMedID- 25262224 | A randomized, prospective trial of operative treatments for hyperparathyroidism in patients with multiple endocrine neoplasia type 1. |
PubMedID- 22584718 | Conversely, hyperparathyroidism associated with multiple endocrine neoplasia type 1 (hyperparathyroidism/multiple endocrine neoplasia type 1) is an asynchronic, asymmetrical multiglandular disease and it is surgically approached by either subtotal parathyroidectomy or total parathyroidectomy followed by parathyroid auto-implant to the forearm. |
PubMedID- 21318141 | Primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1. |
PubMedID- 22584724 | Here we revised the impact of parathyroidectomy (particularly total parathyroidectomy followed by autologous parathyroid implant into the forearm) on bone mineral density values in patients with primary hyperparathyroidism associated with multiple endocrine neoplasia type 1. |
PubMedID- 23363383 | Also covered is the role of pharmacotherapy in controlling acid hypersecretion and other hormonal hypersecretory states these patients may develop, including hyperparathyroidism in patients with multiple endocrine neoplasia type 1 and zes; tumor localization; and the treatment of advanced metastatic disease. |
PubMedID- 19650788 | Objective: limited data have been reported on the effect of parathyroidectomy (ptx) on bone mineral density (bmd) in the setting of patients with hyperparathyroidism (hpt) associated with multiple endocrine neoplasia type 1 (men1). |
PubMedID- 22584719 | The goal of this short review is to discuss the timing of surgery in patients when primary hyperparathyroidism is associated with multiple endocrine neoplasia type 1. |
PubMedID- 20431882 | Background: subtotal parathyroidectomy (sptx) is the treatment of choice for hyperparathyroidism in a patient with multiple endocrine neoplasia type 1 (hpt-men-1). |
PubMedID- 26031271 | Primary hyperparathyroidism in multiple endocrine neoplasia type i usually affects all parathyroid glands, making focused parathyroidectomy (fp) inappropriate. |
PubMedID- 22735224 | Objective: to evaluate frequency, anatomic presentation, and quantities of supernumerary parathyroids glands in patients with primary hyperparathyroidism (hpt1) associated with multiple endocrine neoplasia type 1 (men1), as well as the importance of thymectomy, and the benefits of localizing examinations for those glands. |
PubMedID- 22584713 | Biochemical, bone and renal patterns in hyperparathyroidism associated with multiple endocrine neoplasia type 1. |
PubMedID- 24037737 | A 59-year-old woman with classic manifestations of hyperparathyroidism associated with multiple endocrine neoplasia type 1 presented with a right adrenal mass and two pituitary microadenomas on imaging studies. |
PubMedID- 22508712 | Results: we report two patients with primary hyperparathyroidism due to multiple endocrine neoplasia type 1 who had their first parathyroidectomy at the national institutes of health. |
Page: 1